Jump to main content
Jump to site search

Issue 44, 2013
Previous Article Next Article

Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles

Author affiliations

Abstract

Beta-adrenocepetor antagonists (beta-blockers) alter the nanostructure of lysozyme amyloids, resulting in different drug release profiles.

Graphical abstract: Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles

Back to tab navigation

Supplementary files

Publication details

The article was received on 01 Mar 2013, accepted on 22 Apr 2013 and first published on 23 Apr 2013


Article type: Communication
DOI: 10.1039/C3CC41583J
Citation: Chem. Commun., 2013,49, 5082-5084
  •   Request permissions

    Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles

    J. Mains, D. A. Lamprou, L. McIntosh, I. D. H. Oswald and A. J. Urquhart, Chem. Commun., 2013, 49, 5082
    DOI: 10.1039/C3CC41583J

Search articles by author

Spotlight

Advertisements